12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

• Akanda AKAN stock increased by 28.2% to $0.36 during Thursday's after-market session. Akanda's trading volume hit 4.1 million shares by close, accounting for 474.8% of its average volume over the last 100 days. The company's market cap stands at $12.2 million.
• Lannett LCI shares increased by 8.11% to $0.58. The market value of their outstanding shares is at $24.4 million.
• Geovax Labs GOVX shares rose 7.81% to $0.81. Today's trading volume for this security ended up closing at 1.3 million shares, which is 70.7 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $21.3 million.
• Marker Therapeutics MRKR shares rose 7.05% to $0.38. The market value of their outstanding shares is at $31.5 million.
• Tango Therapeutics TNGX stock rose 5.26% to $7.2. The company's market cap stands at $634.8 million.
• China SXT Pharmaceuticals SXTC stock moved upwards by 5.25% to $0.57. The market value of their outstanding shares is at $1.5 million.

Losers

• AnPac Bio-Medical Science ANPC stock fell 9.9% to $8.0 during Thursday's after-market session. The company's market cap stands at $326.2 million.
• Syros Pharmaceuticals SYRS stock decreased by 7.02% to $4.11. At the close, Syros Pharmaceuticals's trading volume reached 491.7K shares. This is 463.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $83.1 million.
• Minerva Surgical UTRS shares declined by 5.21% to $0.41. At the close, Minerva Surgical's trading volume reached 9.4 million shares. This is 852.6% of its average volume over the last 100 days. The company's market cap stands at $12.2 million.
• Sonoma Pharmaceuticals SNOA stock fell 5.19% to $1.83. Trading volume for this security closed at 422.4K, accounting for 18.1% of its average full-day volume over the last 100 days. The company's market cap stands at $5.6 million.
• Unicycive Therapeutics UNCY shares fell 5.02% to $0.58. The market value of their outstanding shares is at $8.7 million.
• Jasper Therapeutics JSPR stock declined by 5.01% to $1.71. The company's market cap stands at $63.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.